Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma

BACKGROUND: Nucleophosmin-anaplastic lymphoma kinase-expressing (NPM-ALK(+)) T cell lymphoma is an aggressive neoplasm. NPM-ALK, an oncogenic tyrosine kinase, plays a critical role in this lymphoma. Recently, selective ALK inhibitors have emerged as a first-line therapy for this neoplasm. Unfortunat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Hematol Oncol
Huvudupphovsmän: George, Bhawana, George, Suraj Konnath, Shi, Wenyu, Haque, Abedul, Shi, Ping, Eskandari, Ghazaleh, Axelson, Magnus, Larsson, Olle, Kaseb, Ahmed O., Amin, Hesham M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2019
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657048/
https://ncbi.nlm.nih.gov/pubmed/31340850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0768-8
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk